Full Text View
Tabular View
No Study Results Posted
Related Studies
ADI-PEG in Patients With Metastatic Melanoma
This study has been completed.
Study NCT00029900   Information provided by FDA Office of Orphan Products Development
First Received: January 24, 2002   Last Updated: January 31, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melanoma
Neoplasm Metastasis
Additional conditions recognized in this trial
Neoplasms
More general conditions related to this trial
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neoplastic Processes
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Pathologic Processes
Interventions listed in this trial
ADI PEG
Sponsors listed in this trial
FDA Office of Orphan Products Development


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services